The below Parliamentary question was asked by John Glen on 2016-02-29.
To ask the Secretary of State for Health, what the total cost of treating liver disease was in (a) England and (b) each parliamentary constituency in the last year for which figures are available.
Jane Ellison
Information on the total cost of treating liver disease in England and in each parliamentary constituency is not available centrally.
Such information as is available is from reference costs, which are the average unit cost to National Health Service hospital trusts of providing defined services to patients in a given financial year. Reference costs for acute care are collected by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. HRGs are organised by chapters and sub-chapters, representing different body systems, and HRG sub-chapter GC describes hepatobiliary and pancreatic system disorders. The total costs in the following table, calculated from the national average unit costs and activity submitted in reference costs, will therefore include the costs to NHS hospitals of treating liver and liver related diseases, but also the costs of other related disorders.
Estimated total costs (£ millions) to NHS hospitals of treating hepatobiliary and pancreatic system disorders, 2014-15
|
Liver failure disorders |
£17.7 million |
|
Malignant, hepatobiliary or pancreatic disorders |
£54.3 million |
|
Non-malignant, hepatobiliary or pancreatic disorders |
£328.1 million |
|
Total costs |
£400.0 million |
Source: reference costs, Department of Health
Notes:
- The following HRGs are included in the table:
Liver Failure Disorders with Multiple Interventions
Liver Failure Disorders with Single Intervention
Liver Failure Disorders without Interventions, with CC (Complication and Comorbidity) Score 5+
Liver Failure Disorders without Interventions, with CC Score 0-4
Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions
Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 5+
Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 2-4
Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 0-1
Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 6+
Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 3-5
Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 1-2
Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 0
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 9+
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 4-8
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 0-3
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 9+
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 4-8
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 0-3
Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 8+
Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 5-7
Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 2-4
Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 0-1
- These HRGs are common groupings of the International Classification of Disease (ICD-10) codes used to count the number of finished admission episodes with a primary or secondary diagnosis of liver disease or liver related disease. They also include other ICD-10 codes.
“